U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


5AM Ventures VI, L.P. (0001753037)
State location: CA | State of Inc.: DE | Fiscal Year End: 1231
Business Address
4 EMBARCADERO CENTER, SUITE 3110
SAN FRANCISCO CA 94111
(415) 993-8565
Mailing Address
4 EMBARCADERO CENTER, SUITE 3110
SAN FRANCISCO CA 94111
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Camp4 Therapeutics Corp 0001736730 2024-10-10 10 percent owner
Artiva Biotherapeutics, Inc. 0001817241 2024-07-18 10 percent owner
IMARA Inc.
Current Name:Enliven Therapeutics, Inc.
0001672619 2023-02-23 10 percent owner
CinCor Pharma, Inc. 0001868734 2022-01-06 10 percent owner
Vor Biopharma Inc. 0001817229 2021-02-04 10 percent owner
5:01 Acquisition Corp. 0001823465 2020-10-13 10 percent owner


Items 1 - 13

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
D 2021-11-16   Vor Biopharma Inc. 4 S-Sale --I 238870.0000 4595089.0000 1 0001817229 Common Stock
D 2021-11-16   Vor Biopharma Inc. 4 S-Sale --I 91836.0000 1766634.0000 2 0001817229 Common Stock
A 2021-02-09   Vor Biopharma Inc. 4 C-Conversion --I 3308822.0000 3308822.0000 1 0001817229 Common Stock
A 2021-02-09   Vor Biopharma Inc. 4 C-Conversion --I 1414026.0000 4722848.0000 2 0001817229 Common Stock
A 2021-02-09   Vor Biopharma Inc. 4 P-Purchase --I 111111.0000 4833959.0000 3 0001817229 Common Stock
A 2021-02-09   Vor Biopharma Inc. 4 C-Conversion --I 1414026.0000 1414026.0000 4 0001817229 Common Stock
A 2021-02-09   Vor Biopharma Inc. 4 P-Purchase --I 444444.0000 1858470.0000 5 0001817229 Common Stock
D 2021-02-09   Vor Biopharma Inc. 4 C-Conversion --I 45000000.0000 0.0000 6 0001817229 Series A-2 Preferred Stock
D 2021-02-09   Vor Biopharma Inc. 4 C-Conversion --I 19230768.0000 0.0000 7 0001817229 Series B Preferred Stock
D 2021-02-09   Vor Biopharma Inc. 4 C-Conversion --I 19230768.0000 0.0000 8 0001817229 Series B Preferred Stock
- -   Vor Biopharma Inc. 3 - --I 1 0001817229 Series A-2 Preferred Stock
- -   Vor Biopharma Inc. 3 - --I 2 0001817229 Series B Preferred Stock
- -   Vor Biopharma Inc. 3 - --I 3 0001817229 Series B Preferred Stock

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016